Skip to main content
Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
20.13
+0.07 (0.35%)
Mar 9, 2026, 2:05 PM EDT - Market open

Apollomics Revenue

Apollomics had revenue of $8.50M in the half year ending June 30, 2025, with 1,641.80% growth. This brings the company's revenue in the last twelve months to $6.93M, up 229.84% year-over-year. In the year 2024, Apollomics had annual revenue of $198.00K, down -75.88%.

Revenue (ttm)
$6.93M
Revenue Growth
+229.84%
P/S Ratio
6.21
Revenue / Employee
$533,077
Employees
13
Market Cap
43.20M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024198.00K-623.00K-75.88%
Dec 31, 2023821.00K498.00K154.18%
Dec 31, 2022323.00K321.00K16,050.00%
Dec 31, 20212.00K-1.84M-99.89%
Dec 31, 20201.84M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Xilio Therapeutics 31.80M
Veru Inc. 16.89M
Palatin Technologies 8.96M
Lipocine 4.32M
Aligos Therapeutics 2.19M
Revenue Rankings

APLM News

More News